Bullish Moving Averages
13
Bearish Moving Averages
3
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
30.10Prev. Close
27.2500Volume
6000.00Value
180840.00Fundamentals
Market Cap Cr
6.30
Price to Earnings
0.00
Price to Book Value
1.50
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
0.00
Net Profit TTM Cr
0.00
Cash From Operating Activity Cr
-0.77
Return on Equity %
0.86
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
50
Week
80
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
30.14
PIVOT
First Resistance
30.14
Second Resistance
30.15
Third Resistance
30.15
First Support
30.13
Second Support
30.13
Third Support
30.12
Relative Strength Index
54.02
Money Flow Index
62.26
MACD
-0.67
MACD Signal
-0.92
Average True Range
1.31
Average Directional Index
12.57
Rate of Change (21)
14.69
Rate of Change (125)
-8.67
Commodity Channel Index
92
Williams %R
-2.4
BETA
1 Month
0.39
3 Month
0.24
1 Year
3 Year
PRICE CHANGE ANALYSIS
↑ 15.7%
1 Week
Low
High
27.35
30.14
↑ 10.4%
1 Month
Low
High
26.05
30.14
↓ -23.83%
3 Months
Low
High
25.05
37.6
↑ 7.64%
6 Months
Low
High
25.05
43.84
↑ 0.3%
1 Year
Low
High
25.05
43.84
19 Jun 2024
Fabino Life Sciences Ltd - 543444 - Announcement under Regulation 30 (LODR)-Change of Company Name
Announcement under Regulation 30 (LODR) Change in name of Company.
28 May 2024
Fabino Life Sciences Ltd - 543444 - Results For The Year Ended 31St March 2024
Results for the Year ended 31st March 2024
28 May 2024
Fabino Life Sciences Ltd - 543444 - Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th May, 2024.
In continuation of our letter dated May 17, 2024, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements ) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held on 28th May 2024, inter alia considered and approved as attached.
17 May 2024
Fabino Life Sciences Ltd - 543444 - Board Meeting Intimation for Intimation Of Board Meeting For Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For Half Year And Year Ended March 31, 2024.
Fabino Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve In pursuant to Regulation 29(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 this is to inform you, that a meeting of the Board of Directors of Fabino Life Sciences Limited is scheduled to be held on Tuesday, May 28, 2024 at Registered Office of the Company to discuss and approve the Audited Financial Results (standalone and consolidated) for Half Year And Year Ended March 31, 2024 ,thereon and any other business with permission of Chair.
30 Apr 2024
Fabino Life Sciences Ltd - 543444 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyFabino Life Sciences Ltd 2CIN NO.U24100DL2011PLC226781 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.60 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: KANCHI GEHLOT Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: [email protected] Name of the Chief Financial Officer: PANKAJ JAIN Designation: CHEIF FINANCIAL OFFICER EmailId: [email protected] Date: 30/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
16 Apr 2024
Fabino Life Sciences Ltd - 543444 - Certificate As Per Regulation 40 (9) For The Year Ended March 31, 2024
Compliance certificate as per Regulation 40(9) For the Year Ended March 31, 2024.
15 Apr 2024
Fabino Life Sciences Ltd - 543444 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period Ended March 31, 2024.
Compliance certificate Under Regulation 7(3) of SEBI (Listing obligation and Disclosure requirements) Regulations, 2015 for the period ended March 31, 2024
09 Apr 2024
Fabino Life Sciences Ltd - 543444 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Reg 74 (5) of SEBI (DP) Regulation, 2018.
02 Apr 2024
Fabino Life Sciences Ltd - 543444 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Amendment to MOA pursuant to Name Change and Object Change.
02 Apr 2024
Fabino Life Sciences Ltd - 543444 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer''s Report and Voting Results of Postal Ballot
